SCHEMBL22700685

SCHEMBL22700685

CC1=C(C2=C(C)C(=O)c3c(c(C=O)c(O)c(O)c3C(C)C)C2=O)C(=O)c2cc(OC(=O)c3ccccc3)c(O)c(C(C)C)c2C1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.35
ALDH1A1 P00352 4/20 0.35
KMT2A Q03164 4/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
THRB P10828 3/20 0.35
MCL1 Q07820 3/20 0.35
MEN1 O00255 3/20 0.35
USP2 O75604 3/20 0.35
GAA P10253 3/20 0.35
NPSR1 Q6W5P4 3/20 0.35
KDM4E B2RXH2 2/20 0.35
NPC1 O15118 2/20 0.35
LMNA P02545 2/20 0.35
POLB P06746 2/20 0.35
HPGD P15428 2/20 0.35
ALOX12 P18054 2/20 0.35
MAPK1 P28482 2/20 0.35
BLM P54132 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
HSPD1 P10809 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22700494 0.90 KMT2A (0.38) MAPTALDH1A1KMT2ATHRBNPSR1
SCHEMBL22700712 0.87 KMT2A (0.32) MAPTALDH1A1KMT2ASMN1; SMN2THRB
SCHEMBL22700684 0.87 MCL1 (0.39) MAPTALDH1A1KMT2ASMN1; SMN2THRB
SCHEMBL22700754 0.83 ALB (0.34) MAPTALDH1A1KMT2ASMN1; SMN2THRB
SCHEMBL22700702 0.81 KDM4E (0.32) MAPTALDH1A1KMT2ASMN1; SMN2THRB
SCHEMBL22700391 0.81 ALB (0.33) MAPTALDH1A1KMT2ASMN1; SMN2THRB
SCHEMBL22700393 0.81 ALB (0.37) MAPTALDH1A1KMT2ASMN1; SMN2THRB
SCHEMBL22700538 0.80 ALB (0.32) MAPTALDH1A1KMT2ASMN1; SMN2THRB
SCHEMBL22700777 0.80 ALDH1A1 (0.40) MAPTALDH1A1KMT2ASMN1; SMN2THRB
SCHEMBL22686504 0.79 ALB (0.42) MAPTALDH1A1KMT2ASMN1; SMN2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200369618-A1 ASYMMETRIC DERIVATIVES OF POLYPHENOLS OF THE DINAPHTHALINE SERIES, PROCESS OF PREPARING AND USE THEREOF Nearmedic International Limited (CY) 2020-11-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200369618-A1 ASYMMETRIC DERIVATIVES OF POLYPHENOLS OF THE DINAPHTHALINE SERIES, PROCESS OF PREPARING AND USE THEREOF DNM2, DNM1, MAVS MAPT 3116/4885ALDH1A1 859/4885KMT2A 2775/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.